-
Delaying Treatment Resistance
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
2024: The Year in Cancer News
The Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
Cancer Today Editors’ Picks: 2024
Our favorite Cancer Today stories from 2024, as picked by the editors.
-
Rethinking the Role of Radiation
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
December 13: The Week in Cancer News
Active surveillance of DCIS patients may be an alternative to treatment, and guidelines add self-test for HPV.
by Kevin McLaughlin
-
De-escalating Treatment for DCIS
Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
-
December 6: The Week in Cancer News
HPV vaccine credited for decrease in cervical cancer deaths among young women, and new technology extends survival in locally advanced pancreatic cancer.
by Thomas Celona
Cancer Talk
Gaps in Survivorship Care Leave Unmet Needs After Cancer Treatment
A survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
Improving Communication for Deaf Cancer PatientsAfter a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore